Brief: Creo Medical Sees FY26 Revenue Growth Between 50% And 60% On FY25
22/05/2026 07:14
May 22 (Reuters) - Creo Medical Group PLC CREO.L: CREO MEDICAL GROUP - FY25 FINAL RESULTS CREO MEDICAL GROUP PLC: H2 COMMERCIAL MOMENTUM HAS CONTINUED INTO 2026 CREO MEDICAL GROUP: FY25 FINAL RESULTS IN-LINE WITH MARKET EXPECTATIONS AND WITHIN PRIOR MANAGEMENT GUIDANCE CREO MEDICAL GROUP PLC - FY26 FULL YEAR REVENUE GROWTH EXPECTED BETWEEN 50% AND 60% ON FY25 CREO MEDICAL GROUP PLC - OUTSOURCING OF MANUFACTURING EXPECTED TO REDUCE UNDERLYING OPERATING COSTS BY 15% IN FY CREO MEDICAL GROUP PLC - NO DIVIDEND PROPOSED FOR YEAR TO 31 DEC 2025 Source text: ID:nRSV3604Fa Further company coverage: CREO.L ((Reuters.Briefs@thomsonreuters.com;))